| 2025 | van der Zanden B, Kauhl B, Hackert V, Hoebe CJPA. Four million COVID-19 cases in four European cross-border regions reveal minimal cross-border transmission effect on domestic burden: space-time cluster analysis. BMC Infect Dis. 2025;25(1):1528. doi:10.1186/s12879-025-11959-3 |
| 2025 | Hanssen DAT, van Bilsen CJA, den Heijer CDJ, Stabourlos C, Moonen CPB, de Vries R, Brinkhues S, Philippsen D, van der Zanden BAM, Dukers-Muijrers NHTM, Hoebe CJPA, Savelkoul PHM, van Loo IHM. Nucleocapsid-directed antibody testing is unsuitable to estimate hybrid immunity against SARS-CoV-2, a longitudinal cross-border study in the Meuse-Rhine Euroregion. J Clin Virol. 2025;177:105780. doi:10.1016/j.jcv.2025.105780 |
| 2024 | van Bilsen CJA, Brinkhues S, Hoebe CJPA, Stabourlos C, Moonen CPB, Demarest S, Hanssen DAT, van Loo IHM, Savelkoul PHM, Philippsen D, van der Zanden BAM, Dukers-Muijrers NHTM. Cross-border mobility in the Meuse-Rhine Euroregion: impact of COVID-19 border restrictions on everyday activities and visiting social network members. Front Public Health. 2024;12:1281072. doi:10.3389/fpubh.2024.1281072 |
| 2024 | van der Zanden BAM, Hoebe CJPA, Horstman K. European policies for public health in border regions: no European mindset as yet. BMC Public Health. 2024;24(1):746. doi:10.1186/s12889-024-18175-9 |
| 2024 | van der Zanden B, Nemer L. Innovation in border regions: from inequality to equity! Starting with acknowledgment in policy. Eur J Public Health. 2024;34(Suppl 3):ckae144.2193. doi:10.1093/eurpub/ckae144.2193 |
| 2024 | van der Zanden B, Mekel O, Struß M. Adapting the Place Standard Tool for Border Regions: The Euregional Approach. Eur J Public Health. 2024;34(Suppl 3):ckae144.1428. doi:10.1093/eurpub/ckae144.1428 |
| 2023 | Stabourlos C, van Bilsen CJA, Brinkhues S, Moonen CPB, Demarest S, Hanssen DAT, van Loo IHM, Savelkoul PHM, Philippsen D, van der Zanden BAM, Dukers-Muijrers NHTM, Hoebe CJPA. COVID-19 pandemic response in the Meuse-Rhine Euroregion: methods, participation and recommendations of a longitudinal cross-border study. Arch Public Health. 2023;81(1):91. doi:10.1186/s13690-023-01102-6 |
| 2023 | van Bilsen CJA, Stabourlos C, Moonen CPB, Brinkhues S, Demarest S, Hanssen DAT, van Loo IHM, Savelkoul PHM, Philippsen D, van der Zanden BAM, Dukers-Muijrers NHTM, Hoebe CJPA. Differences in non-positive intention to accept the COVID-19 booster vaccine between three countries in the cross-border region Meuse-Rhine Euroregion: The Netherlands, Belgium, and Germany. Vaccine X. 2023;14:100306. doi:10.1016/j.jvacx.2023.100306 |
| 2022 | van der Zanden B. Concept of cross border policy in public health: what is it and how does it. Eur J Public Health. 2022;32(Suppl 3):ckac129.217. doi:10.1093/eurpub/ckac129.217 |
| 2022 | van der Zanden B. euPrevent. Eur J Public Health. 2022;32(Suppl 3):ckac129.487. doi:10.1093/eurpub/ckac129.487 |
| 2020 | Schichel MCP, Veenstra MY, Kempen GIJM, de Vugt ME, van der Zanden BAM, Verhey FRJ. Senior Friendly Communities: designing an approach for cross-border exchange of public health policy. Health Policy. 2020;124(10):1129-1136. doi:10.1016/j.healthpol.2020.05.020 |
| 2015 | van der Zanden B, Feldhoff KH. Promoting scaling up in border region: the example euPrevent. Eur J Public Health. 2015;25(Suppl 3):ckv169.014. doi:10.1093/eurpub/ckv169.014 |
| 2014 | van der Zanden B, Schenkeveld C. Lessons from cross-border emergency care along the Western border of Germany. Eur J Public Health. 2014;24(Suppl 2):cku164.050. doi:10.1093/eurpub/cku164.050 |
| 2004 | van der Zanden B, Kuijpers A, Philippsen D, Houben T. Präventionsstrukturen und -konzepte in der Euregio Maas-Rhein Interreg III-Projekt: Risikoverhalten Jugendlicher. Gesundheitswesen. 2004;66(8/09):1. doi:10.1055/s-2004-833844 |
| 2004 | Philippsen D, van der Zanden B, Houben T. Risikoverhalten Jugendlicher in der Euregio Maas-Rhein: Unterschiede und Gemeinsamkeiten von Prävalenzen und Präventionsstrukturen. Gesundheitswesen. 2004;66:598. |